Aug 27, 2023–CHOSA Oncology AB’s postpones publication of the interim report Q2 (regulatory)Jun 30, 2023–ASCO 2023 - good news for CHOSAJun 03, 2023–CHOSA Oncology AB publishes results from clinical phase 2 trial of liposomal formulation in breast cancer, using predictive marker for cisplatin (regulatory)
